SCHEMBL6861301

SCHEMBL6861301

CC(=O)O[C@@H]1C[C@@H]2C[C@@H](C1=O)C2(C)C

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 14/20 0.38
ALOX15 P16050 1/20 0.36
TSHR P16473 1/20 0.36
CYP19A1 P11511 2/20 0.33
OPRM1 P35372 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11194228 0.81 ALOX15 (0.36) ALOX15TSHRCYP19A1
SCHEMBL30515432 0.81 ALOX15 (0.36) ALOX15TSHRCYP19A1
SCHEMBL12812311 0.70 TSHR (0.36) TSHRCYP19A1
SCHEMBL17204821 0.68
SCHEMBL17213193 0.68
SCHEMBL19621509 0.67 TSHR (0.38) TSHR
SCHEMBL6861304 0.67 TSHR (0.37) OPRK1ALOX15TSHRCYP19A1
SCHEMBL19621415 0.66 TSHR (0.36) TSHR
SCHEMBL3707344 0.66 TSHR (0.36) TSHR
SCHEMBL13255134 0.66 TSHR (0.41) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1069123-B1 PROCESS FOR PRODUCING BENZOTHIOPHENECARBOXYLIC ACID AMIDE DERIVATIVES SHIONOGI & CO (JP) 2004-11-10 EP disclosed
US-20020161242-A1 Process for preparing benzothiophenecarboxamide derivatives HONMA TSUNETOSHI (JP) 2002-10-31 US disclosed
US-20020156297-A1 Process for preparing benzothiophenecarboxamide derivatives OKADA TETSUO (JP) 2002-10-24 US disclosed
US-6399788-B1 AMIDATION SHIONOGI & CO., LTD. (JP) 2002-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161242-A1 Process for preparing benzothiophenecarboxamide derivatives PGD, HPD, PTGS2 OPRK1 515/4885ALOX15 223/4885TSHR 1965/4885
US-20020156297-A1 Process for preparing benzothiophenecarboxamide derivatives PGD, HPD, PTGS2 OPRK1 515/4885ALOX15 223/4885TSHR 1965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.